about
P361
The database for aggregate analysis of ClinicalTrials.gov (AACT) and subsequent regrouping by clinical specialtyStreamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Trials: Recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team.Clinical Trial Electronic Portals for Expedited Safety Reporting: Recommendations from the Clinical Trials Transformation Initiative Investigational New Drug Safety Advancement Project.The Clinical Trials Transformation Initiative (CTTI).Paving the way to a more effective informed consent process: Recommendations from the Clinical Trials Transformation Initiative.Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia: Recommendations of the Clinical Trials Transformation Initiative AntibClinical trials recruitment planning: A proposed framework from the clinical trials transformation initiative.The Clinical Trials Transformation Initiative: Methodology supporting the mission.Patient engagement in clinical trials: The Clinical Trials Transformation Initiative's leadership from theory to practical implementation.The Clinical Trials Transformation Initiative: Looking back, looking forward.A decade of the Clinical Trials Transformation Initiative: What have we accomplished? What have we learned?The Clinical Trials Transformation Initiative: innovation through collaboration.Perceived barriers to pediatrician and family practitioner participation in pediatric clinical trials: Findings from the Clinical Trials Transformation Initiative.Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative.
P921
Q34206436-bfc70569-40d0-de0f-b948-a49ee4370e24Q36092238-569ccd22-4b97-df31-2af3-10a3bb340456Q37723012-1cfd0469-4d19-4067-a86c-9602175e1ba5Q37856607-b9534e7a-4f43-deea-7aa8-e92483af2966Q38872067-beb516f7-41c4-ba12-948d-4d04e20d59dbQ38915822-ba29ed76-4991-16d8-aeae-695997ab32adQ47560956-92f22c42-4dad-6788-23c9-34103b098eacQ49921590-f29a0467-4911-9229-7d16-37e685282769Q49921604-31d30939-4b59-edd7-f89e-99557e2653f4Q49921616-11ef8381-4b14-2dfe-ff87-dbdfb89d1b3aQ49921626-5c34a931-417b-5950-c3e2-a3250b05ecbaQ54198280-aa801b3e-40cd-081c-0a8b-85a574f70edfQ55087105-7f0a0c7a-4e74-6b0e-2432-892f0fbdb75cQ55116538-161d8a4b-447c-b924-b05e-31510679c0ad
P921
description
Duke University program to present clinical trial data
@en
name
Clinical Trials Transformation Initiative
@en
type
label
Clinical Trials Transformation Initiative
@en
prefLabel
Clinical Trials Transformation Initiative
@en